Showing 24 results for Diabetes Mellitus
Seyed Zanyar Athari, Mir Alireza Nourazar, Mohammadreza Nasirzadeh,
Volume 16, Issue 3 (5-2022)
Abstract
Background and objectives: Increased oxidative stress and altered antioxidant levels play an essential role in the pathogenesis of diabetes mellitus. Menopause is associated with increased food intake, weight gain, metabolic disorders, and increased level of inflammatory and oxidative stress factors. This study evaluated effects of oleuropein extract on brain tissue and serum oxidative status in ovariectomized diabetic rats.
Methods: In this study, 40 female Wistar rats weighing 250±20 grams were randomly divided into four groups: control, sham (surgery without ovariectomy), ovariectomy+diabetes, and ovariectomy+diabetes+oleuropein supplementation. Diabetes was induced by intraperitoneal injection of streptozotocin. The rats in the treatment group received 60 mg/kg of oleuropein for 30 days by oral gavage. Finally, blood glucose, superoxide dismutase, glutathione peroxidase, total antioxidant capacity, and malonaldehyde levels were evaluated in serum and brain tissue samples.
Results: Weight, blood glucose level, and antioxidant enzymes activity increased significantly in the ovariectomy+diabetes group compared to the control group.
Conclusion: This study suggested that the administration of oleuropein extract has beneficial effects on blood glucose level and antioxidant status in serum and brain tissue of ovariectomized diabetic rats.
Ali Nouri, Parvin Farzanegi, Mohammad Ali Azarbayjani,
Volume 16, Issue 4 (7-2022)
Abstract
Background and objectives: Diabetes mellitus is the most common metabolic disorder in the world. Here, we evaluated effects of resveratrol supplementation alone and combined with exercise on blood glucose, insulin, lipid profile, apoptosis biomarkers, and expression of farnesoid X receptor (Fxr), liver X receptor (Lxr), and sirtuin 1 (Sirt 1) genes in the liver of type 1 diabetic rats.
Methods: Streptozotocin was used to induce type 1 diabetes in Wistar rats. The rats were randomly assigned into seven groups. After treatment with resveratrol alone or combined with exercise training, the animals were sacrificed and lipid profile and levels of blood glucose and insulin were measured. Hepatocyte apoptosis was assessed by measuring the level of Bax and Bcl2 proteins using enzyme-linked immunosorbent assay kits. Expression of Fxr, Lxr, and Sirt1 was evaluated using real-time polymerase chain reaction. Comparison of the mean levels of all variables between different groups was performed using one-way analysis of variance, at statistical significance level of 0.05.
Results: Resveratrol significantly reduced the level of blood glucose and insulin compared with the control groups (p<0.001). It also significantly affected the lipid profile (p<0.001). Diabetes was significantly associated with decreased expression of Sirt1, Lxr, and Fxr and increased hepatocyte apoptosis. Resveratrol significantly improved the expression of all three genes (p<0.01). Overall, resveratrol supplementation combined with exercise was more effective than other methods.
Conclusion: The results indicate that that combination of resveratrol therapy with exercise could be beneficial for diabetic patients. However, more studies are needed to confirm this finding.
Mahdi Ghafari, Ebrahim Banitalebi, Ali Nabipur,
Volume 16, Issue 5 (9-2022)
Abstract
Background and objectives: Considering racial/ethnic differences is necessary when recommending lifestyle modifications for patients with diabetes. Racial/ethnic diversity may affect hypoadiponectinemia responses to exercise training among individuals with type 2 diabetes. This systematic review and meta-analysis is the first to investigate effects of exercise training on circulating adiponectin concentrations in Iranians with type 2 diabetes.
Methods: Literature searches of the Cochrane Central Register of Controlled Trials were carried out using the following search strategy: [exercise OR training OR physical activity OR Training] AND diabetes AND adiponectin. Next, RCTs were included and compared with each type of supervised exercise (aerobic training, resistance training, or combined training). Pooled intervention effects were evaluated and reported as standardized mean difference (MD) and 95% confidence intervals using a random effects model. Subgroup and sensitivity analysis was performed for study heterogeneity and following primary screening full text of the articles was evaluated.
Results: Fourteen studies with 444 individuals (236 men and 128 women) were included in the analysis. The age of the participants ranged between 18 and 60 years. The number of exercise sessions per week ranged between 3 and 5. The duration of interventions ranged between 6 and 12 weeks. The meta-analysis showed that adiponectin levels increased significantly in diabetic subjects after physical activity (MD: 0.72 ng/dl, p<0.001,), but the heterogeneity of the study remained significant (I2= 89%).
Conclusion: Overall, physical exercise, particularly aerobic exercise, increases adiponectin levels in Iranians with diabetes. However, this effect of exercise may be influenced by race/ethnic differences, type of training, frequency, type of adiponectin measurement, and complex and heterogeneous exercise responses of individual with diabetes.
Nasrin Ramezani, Mahshid Dezhan, Saide Saadaat Khalili, Nader Shakeri, Kayvan Khoramipour,
Volume 17, Issue 5 (9-2023)
Abstract
Background: Omentin-1 plays an important role in insulin function. Despite numerous studies, the effect of interval training on this adipokine is still vague. This study aimed to elucidate the effect of high-intensity interval training (HIIT) on serum glucose, insulin, insulin resistance (IR), omentin-1 serum levels, and gene expression in the visceral adipose tissue in type 2 diabetic (T2D) rats.
Methods: In an experimental study, 20 male rats (8-10 weeks, weight: 250-270 g) were randomly divided into 2 groups: diabetic control (N=10) and diabetic training (N=10). The training protocol was 30 minutes of HIIT (1-min run, 2-min rest) performed 5 days a week for 4 weeks. Fasting blood glucose, insulin resistance, omentin-1 serum level, and gene expression were measured in the visceral fat 48 hours after the last exercise for both groups.
Results: The HIIT resulted in lower serum glucose and insulin resistance (P = 0.001), higher serum omentin-1 levels (P = 0.001), and higher visceral fat gene expression (P = 0.004) in the training group compared to the control group.
Conclusion: Lower serum glucose and insulin resistance and higher omentin-1 serum levels and gene expression in the training group can prove the effectiveness of HIIT training in T2D, although further research is required.
Misha Antani, Anjali Goyal, Jalashree Rana,
Volume 18, Issue 1 (1-2024)
Abstract
Background: A higher occurrence of raised homocysteine levels has been reported in individuals with type 2 diabetes (T2D), particularly those with macroangiopathy and nephropathy. Given that hyperhomocysteinemia is a risk factor for T2D, mitigating this condition could potentially benefit T2D patients. This study aimed to investigate the influence of homocysteine on T2D and cardiovascular disease (CVD), as well as the factors that modify homocysteine levels.
Methods: This cross sectional, observational study was conducted on 122 individuals in a tertiary care center in Western India. Data related to anthropometry, demography, and biochemistry were gathered following established standards. Statistical analysis was performed using Chi-square test. A P-value of <0.05 was considered statistically significant.
Results: The findings indicated a significantly larger percentage of hyperhomocysteinemia in males, smokers, and individuals with elevated fasting blood sugar and HbA1c levels. The proportion of subjects with high homocysteine levels was notably greater in those with high total cholesterol and triglyceride levels. A significant correlation was observed between increased serum homocysteine levels and decreased serum folic acid and vitamin B12 levels in patients with ischemic heart disease.
Conclusion: Elevated homocysteine levels are observed in smokers and diabetic patients, potentially leading to CVD. Furthermore, this study found a correlation between an increase in serum homocysteine levels and a decrease in serum folic acid and vitamin B12 levels in patients with ischemic heart disease.
Chandralekshmy Chandrika, Archana Jayan, Fathima Beevi Osman,
Volume 18, Issue 2 (3-2024)
Abstract
Background: Type 2 DM is a heterogeneous group of disorders characterized by insulin resistance, impaired insulin secretion, increased glucose production, and abnormal fat metabolism. Diabetes mortality primarily results from microvascular complications such as diabetic retinopathy, nephropathy, and neuropathy, as well as macrovascular complications like coronary artery, peripheral vascular, and cerebrovascular diseases. Patients with diabetes usually have changes in adipose tissue metabolism and abnormalities in the secretion of adipokines such as leptin. The present study aims to study the relationship between serum leptin levels and lipid profile parameters among non-obese type 2 diabetes mellitus patients and non-diabetic individuals.
Methods: This hospital-based cross-sectional study was conducted among 41 type 2 diabetic patients and 41 non-diabetic individuals of both sexes between the ages of 40 and 70. Fasting blood glucose (FBS), serum leptin, total cholesterol (TC), triglyceride (TG), and high-density lipoprotein (HDL) levels were assayed.
Results: The mean serum leptin levels among diabetic patients were lower than those of non-diabetic individuals, and this difference in mean was statistically significant. The study showed a significant negative correlation between serum leptin, TC, TG, and low-density lipoprotein (LDL), and a positive correlation with HDL. In the final regression model, serum leptin showed a statistically significant association with FBS and HDL.
Conclusion: This study demonstrated that serum leptin levels can be a strong predictor of low HDL levels in diabetic patients. It can also contribute to raised levels of total cholesterol, triglyceride, and LDL, which are responsible for macrovascular complications in diabetics.
Piyushkumar Mansinh Pargi , Manish Barvaliya , Bhargav Purohit,
Volume 18, Issue 4 (7-2024)
Abstract
Background: Although the anti-diabetic effects of various Ficus species have been investigated in animal models, research on the blood glucose-lowering potentials of Ficus lacor Buch Ham bark remains sparse. This study evaluated the blood glucose-lowering potentials of an aqueous extract derived from Ficus labor bark in a diabetic rabbit model.
Methods: Diabetes was induced in rabbits through intravenous administration of alloxan monohydrate (120 mg/kg). 36 rabbits were divided into six groups, each consisting of six animals. Control groups included a non-diabetic control (Distilled water) and a diabetic control (Distilled water). Two experimental groups received Ficus lacor extract at doses of 100 mg/kg (Low-dose) and 200 mg/kg (High-dose) orally for six weeks. Metformin was used as an active control. A non-diabetic group (Extract control) was also administered Ficus lacor extract at 200 mg/kg. Fasting blood sugar (FBS) and post-prandial blood sugar (PP2BS) levels were measured weekly over the 6 weeks. The percentage reduction in blood glucose levels was calculated and compared for each group.
Results: The administration of both low-dose and high-dose Ficus lacor extracts resulted in significant reductions in FBS and PP2BS levels in diabetic rabbits. After six weeks, the low-dose extract group exhibited an average reduction of 38.3% in FBS and 40.5% in PP2BS, whereas the high-dose extract group showed average reductions of 35.3% in FBS and 36.3% in PP2BS.
Conclusion: The aqueous extract of Ficus lacor bark demonstrates substantial glucose-lowering activity, indicating its potential utility as a therapeutic agent in diabetes management.
Mohammed Fabin, Jayakrishnan Jayakumar, Swathy Shanker,
Volume 18, Issue 4 (7-2024)
Abstract
Background: Diabetes Mellitus (DM) is a metabolic disorder whose pathophysiology has been linked to various genetic and environmental factors. The main mechanism of the development of complications has been implicated as inflammation-mediated. Various blood cell parameters are being used as early indicators of inflammation-mediated endothelial dysfunction; thereby predicting the severity or prognosis of DM. In this study, we aimed to evaluate the role of platelet-to-lymphocyte ratio (PLR) in predicting glycemic control in patients with DM.
Methods: This is a retrospective, hospital-based study conducted from August 2023 to December 2023. A total of 134 patients were included in the study. The hematological and biochemical reports of the study population were retrieved, and the data obtained was analyzed using SPSS software version 16.0.
Results: In this study, it has been found that PLR is significantly increased in patients suffering from DM with poor glycemic control compared to those patients with good glycemic control (P<0.001). In concordance with other studies, a positive association was observed between PLR and disease severity.
Conclusion: Based on the findings of the study, PLR may be used as a predictive marker in assessing the severity and prognosis of DM; however, the exact cut-off value is yet to be determined.
Israa Elgaily, Abdelkarim A. Abdrabo,
Volume 18, Issue 5 (9-2024)
Abstract
Background: Various analytes are used to assess glycemic control in laboratory medicine. Glucose measurements show current glucose levels, but sample stability can be influenced by diet and stress. Hemoglobin A1c (HbA1c) is the best marker for long-term control but can be affected by elevated urea levels. This study compared glycated albumin (GA) and HbA1c in diabetic patients undergoing hemodialysis.
Methods: A comparative cross-sectional study was conducted with a sample size of 280 volunteers. Among these, there were 115 diabetic patients with end-stage renal disease (ESRD), 95 diabetic patients without ESRD, and 75 non-diabetic patients with ESRD. Laboratory measurements included HbA1c, GA, urea, and creatinine, assessed using standard laboratory techniques. Data analysis was carried out using SPSS statistical software.
Results: Levels of HbA1c were lower in diabetic patients with ESRD compared to diabetic patients without ESRD. In contrast, GA levels were higher in diabetics with ESRD. A significant negative association was observed between HbA1c levels and urea levels. However, creatinine levels were not associated with either HbA1c or GA.
Conclusion: The estimation of glycated hemoglobin levels can be affected by high blood urea. Therefore, GA may be a better glycemic indicator for diabetic patients with ESRD.
Habibeh Sadat Mosavi , Mohammad Taher Hojjati , Khodaberdi Kalavi,
Volume 18, Issue 5 (9-2024)
Abstract
Background: Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia, disturbed lipid metabolism, and cardiovascular disease (CVD). Poor glycemic control results in lipid and lipoprotein abnormalities, suggesting that dyslipidemia is secondary to insulin resistance or factors closely related to insulin resistance. Glaciated hemoglobin (HbA1c) is a routinely used marker for long-term glycemic control. This form of hemoglobin is chemically processed through post-translational glycosylation that reflects the plasma glucose concentration during the last two to three months.
Methods: This cross-sectional study was conducted on blood samples from 592 cases referred to Dezyani Specialty Clinic, affiliated with the Golestan University of Medical Sciences. In patients with diabetes mellitus (DM) and non-diabetic individuals, hemoglobin A1c (HbA1c), total cholesterol (T-chol), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured.
Results: In the study, there were 460 female participants (76.9%) and 132 male participants (23.1%). Among them, 403 (67.4%) were diabetic patients, and 193 (32.4%) were non-diabetic. HbA1c levels were significantly lower in younger individuals than in middle-aged participants (p=0.000). No significant difference was found between middle-aged and older individuals (p>0.121). LDL levels were significantly lower in the young group than in the middle-aged group (p<0.001). Total cholesterol (TC) was also significantly lower in the young group compared to middle-aged and older groups (p<0.001).
Conclusion: HbA1c can be a helpful lipid and glycemic control marker in diabetes.
Mahendran Kanumuru, Sridevi Nutakki ,
Volume 18, Issue 6 (11-2024)
Abstract
Background: Type 2 diabetes mellitus (T2DM) is a non-communicable disease, manifesting hyperinsulinemia, insulin resistance, hyperglycemia, and low-grade chronic inflammation associated with various micro and macrovascular complications. The present study aimed to estimate vitamin D (Vit D) levels, total antioxidant capacity, and malondialdehyde (MDA) levels in T2DM patients compared with healthy individuals. In addition, we assessed Vit D, total antioxidant capacity, and MDA levels in patients with T2DM and their association with HbA1c, insulin resistance and lipid profile parameters.
Methods: Seventy patients with T2DM aged 35 to 50 years were selected and 70 healthy age-matched subjects were selected as controls. Serum Vit D and insulin were estimated by the enzyme-linked immunosorbent assay (ELISA). Glycosylated hemoglobin (HbA1C) was assessed by high-performance liquid chromatography (HPLC) method and other routine lipid profile investigations were carried out using a Beckman Coulter fully automated analyzer.
Results: Vitamin D levels significantly decreased in T2DM patients. HbA1C and insulin resistance values are significantly increased in type 2 diabetic patients. Vitamin D levels negatively correlated with MDA, insulin resistance, and HbA1c, while positively correlated with total antioxidant capacity. Nevertheless, there is no significant correlation between lipid profile parameters.
Conclusion: Vitamin D deficiency may be one of the vital risk factors responsible for increased oxidative stress in patients with T2DM. Regular monitoring and supplementation of Vit D are beneficial for the reduction of oxidative stress and vascular complications in these patients.
Sharabeh Hezarkhani , Khosro Ghojoghi , Sara Hosseinzadeh , Naser Behnampour , Farshid Fathabadi , Zahra Hesari , Hamid Reza Joshaghani ,
Volume 18, Issue 6 (11-2024)
Abstract
Background: Leptin and adiponectin, two members of the adipokine family, play roles in increasing lipid metabolism and inhibiting lipogenesis. Reduced levels of these cytokines are associated with obesity and insulin resistance. This study aimed to determine the serum levels of leptin and adiponectin in type-2 diabetic patients with and without metabolic syndrome compared to a control group.
Methods: Three groups of individuals participated in this study: 47 type-2 diabetic patients with metabolic syndrome (DM+MetS), 25 type-2 diabetic patients without metabolic syndrome (DM-MetS), and 40 individuals with no history of diabetes or metabolic syndrome (Control group). Fasting blood samples were collected, and serum levels of fasting blood sugar, cholesterol, triglycerides, HDL-cholesterol, and LDL-cholesterol were measured using the enzymatic method. Blood pressure, height, and weight were recorded using stadiometers, while leptin and adiponectin levels were determined via enzyme-linked immunosorbent assay.
Results: A significant difference was observed between the DM+MetS group and the DM-MetS group in serum leptin (p = 0.004) and adiponectin (p < 0.001) levels. In patients with type-2 diabetes and metabolic syndrome, serum leptin (p = 0.530) and adiponectin (p < 0.001) levels were lower compared to the control group.
Conclusion: A decrease in the serum levels of key adipokines, such as leptin and adiponectin, in type-2 diabetic patients may serve as a predictor of metabolic syndrome.
